本文へ

This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy別ウィンドウで開く (opens in a new window).

Agree

ATLAS Asia Clinical Trials Network for Cancers Project
menu
  1. Home
  2. International Medical Care
  3. NCC Today-Blog
  4. We provide current multimodal-therapy, including chemotherapy and chemoradiotherapy for the head and neck cancer and esophageal cancer, with consideration of each patient’s situation.

We provide current multimodal-therapy, including chemotherapy and chemoradiotherapy for the head and neck cancer and esophageal cancer, with consideration of each patient’s situation.

Kazuki Yokoyama

2023/10/15

  • Our department provides the current multimodal-therapy for head and neck cancer and esophageal cancer and has one of the highest number of treatment experiences in Japan.
  • We hold regular weekly conferences with physicians who are experts in head and neck cancer and esophageal cancer in various fields, such as head and neck surgery, esophageal surgery, gastrointestinal endoscopy, radiation therapy, diagnostic radiology, and pathology, to plan the best treatment for each patient.
  • In our practice, we explain the details of treatment to patients and their families, discuss them thoroughly, and make sure that everyone reaches a consensus.
  • We provide “cancer genome medicine,” in which the genes of each individual’s cancer are examined and treatment is provided according to the changes in the genes.
  • We are conducting clinical trials of new drugs and translational research in collaboration with domestic and international institutions.

PAGE TOP